Status message

Active context: kki_bg_colors_yellow

For Researchers-- About the Clinical Trials Unit

About the Clinical Trials Unit

The Clinical Trials Unit at Kennedy Krieger Institute is a resource that researchers and clinicians can use to apply and participate in future industry- and privately- sponsored clinical trials. It serves as a center of excellence within the Institute for the development, coordination, and implementation of clinical trials designed to advance the scientific knowledge of a wide range of neurological disorders. The Clinical Trials Unit focuses on investigation of drug therapies with the potential to modify diseases previously considered untreatable, such as fragile x syndrome, tuberous sclerosis complex, and autism.

We are currently accepting participants for active trials. Please contact us at if you have any questions or are interested in more information about a specific trial.

Bradley L. Schlaggar, M.D., Ph.D., Named President and CEO of Kennedy Krieger Institute

We’re thrilled to welcome Bradley L. Schlaggar, M.D., Ph.D., to the Kennedy Krieger family as our next President and CEO.

Learn more.


Read inspiring stories, news and updates about the Institute's patient care, research, special education, professional training, and community programs.